IGF2AS Polyclonal Antibody, FITC Conjugated
Product Specifications
Background
This gene expresses a paternally imprinted antisense transcript of the insulin-like growth factor 2 gene. The transcript is overexpressed in Wilms' tumor. This gene is predicted to be non-coding because the predicted protein is not conserved in any other species and the majority of transcripts would be candidates for non-sense mediated decay (NMD) if a protein were expressed. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009]
Synonyms
IGF2 Antisense Gene Protein 1; IGF2 Antisense RNA Non-Protein Coding; IGF2 Antisense RNA 1; IGF2 Antisense RNA; IGF2 AS1; IGF2AS; Insulin Like Growth Factor 2, Antisense; PEG8; IG2AS_HUMAN; PEG8/IGF2AS Protein; Putative Insulin-Like Growth Factor 2 Antisense Gene Protein 1.
Host
Rabbit
Immunogen
101-168/168
Target
IGF2AS
Clonality
Polyclonal
Isotype
IgG
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human IGF2AS
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Predicted Cross Reactivity
Human
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
